Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2004-09-30
2010-10-26
Fubara, Blessing M (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S428000, C424S422000, C424S423000, C424S078350
Reexamination Certificate
active
07820194
ABSTRACT:
An improved viscoelastic composition useful in the performance of ophthalmic surgical procedures and especially cataract procedures is disclosed. The embodiments of the composition comprise combinations of sodium hyaluronate and chondroitin sulfate and exhibit an improved rheological profile.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4486416 (1984-12-01), Soll et al.
patent: 4920104 (1990-04-01), DeVore et al.
patent: 4971955 (1990-11-01), Soll et al.
patent: 5166331 (1992-11-01), della Valle et al.
patent: 5273056 (1993-12-01), McLaughlin et al.
patent: 5290552 (1994-03-01), Sierra et al.
patent: 5409904 (1995-04-01), Hecht et al.
patent: 5422376 (1995-06-01), Webb
patent: 5492936 (1996-02-01), Francese et al.
patent: 5498606 (1996-03-01), Soll et al.
patent: 5501706 (1996-03-01), Arenberg
patent: 5627162 (1997-05-01), Gwon et al.
patent: 5792103 (1998-08-01), Schwartz et al.
patent: 5811453 (1998-09-01), Yanni et al.
patent: 5814621 (1998-09-01), Kanaya et al.
patent: 5929050 (1999-07-01), Petito
patent: 5972326 (1999-10-01), Galin et al.
patent: 6051560 (2000-04-01), Chang et al.
patent: 6086597 (2000-07-01), Fergeus et al.
patent: 6632423 (2003-10-01), Doshi et al.
patent: 6906044 (2005-06-01), Hermida Ochoa
patent: 0 136 782 (1985-04-01), None
patent: 0 214 853 (1987-03-01), None
patent: 0 341 007 (1989-11-01), None
patent: 0 781 547 (1997-07-01), None
patent: WO 93/25187 (1993-12-01), None
patent: WO 94/25004 (1994-11-01), None
patent: WO 97/41899 (1997-11-01), None
patent: WO 98/26777 (1998-06-01), None
patent: WO 98/41171 (1998-09-01), None
patent: WO 99/24070 (1999-05-01), None
patent: WO 01/68079 (2001-09-01), None
patent: WO 02/40056 (2002-05-01), None
Nishimura et al. (“Role of chondroitin sulfate-hyaluroniuc interactions in the viscoelastic properties of extracellular matrices and fluids,” in Biochemica et Biophysica Acta, 1380 (1998) 1-9).
Nishimura et al. (“Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids,” in Biochemica et Biophysica Acta, 1380 (1998) 1-9).
Adams, “Viscosupplementation: A Treatment for Osteoarthritis”, J. Rheumatology, 1993, vol. 20(39):2.
Adams, “An Analysis of Clinical Studies of the Use of Crosslinked Hyaluronan, Hylan, in the Treatment of Osteoarthritis,” 1993, J. Rheumatology, vol. 20(30):16-18.
Balazs et al., “Viscosupplementation: A New Concept in the Treatment of Osteoarthritis,” J. Rheumatology, 1993, vol. 20(39):3-9.
Bobic, “Autologous Chondrocyte Transplantation,” Am. Acad. Orthopaedic Surgeons Annual Meeting, Day 2, pp. 1-6 (2000).
Buckwalter et al., “Restoration of Injured or Degenerated Articular Cartilage,” J Am. Acad. Orthopaedic Surgeons, 1994, vol. 2(4):192-201.
Kelly et al., “In Vitro Release Kinetics of Gentamycin from a Sodium Hyaluronate Gel Delivery System Suitable for the Treatment of Peripheral Vestibular Disease,” Drug Dev. Indust. Pharm., 1999, vol. 25(1):15-20.
Krupla et al., “The Efficacy of Hyaluronic Acid Foam as a Middle Ear Packing Agent in Experimental Tympanoplasty,” Am J. Otol., 1998, vol. 19:546-550.
Laurent et al., “Hyaluronic Acid Reduces Connective Tissue Formation in Middle Ears Filled With Absorbable Gelatin Sponge,” Am. J. Otolaryogol, 1986, vol. 7(3):181-186.
Merchant et al., “Current Status and Future Challenges of Tympanoplasty,” Eur. Arch. Otorhinolaryngol, 1998, vol. 255:221-228.
Miyauchi et al., “The Optimal Molecular Weight of Dispersive Type Sodium Hyaluronate for the Reduction of Corneal Endothelial Damage induced by Sonication, Irrigation, and Aspiration,” Jpn J Ophthalmol., 2001, vol. 45:339-347.
Pelletier et al., “The Pathophysiology of Osteoarthritis and the Application of the Use of Hyaluronan and Hylan as Therapeutic Agents in Viscosupplementation,” J. Rheumatology, 1993, vol. 20(39):19-24.
Peyron “Intraarticular Hyaluronan InjectiOns in the Treatment of Osteoarthritis: State-of-the-Art Review,” J. Rheumatology, 1993, vol. 20(39):10-15.
Poyer et al., “Quantitative Method to Determine the Cohesion of Viscoelastic Agents by Dynamic Aspiration,” J. Cataract Refract. Surg., 1998, vol. 24:1130-1135.
Rosiak et al., “Radiation Formation of Hydrogels for Biomedical Purposes. Some Remarks and Comments,” Radiat. Phys. Chem., 1995, vol. 46(2):161-168.
Arshinoff et al., “New Classification of Ophthalmic Viscosurgical Devices—2005”, J Cataract Refractive Surgery, vol. 31:2167-2171, 2005.
Praveen et al., “DisCoVisc versus the Soft-Shell Technique Using Viscoat and Provisc in Phacoemulsification: Randomized Clinical Trial”, J Cataract Refractive Surgery, vol. 34:1145-1151, 2008.
Doshi Uday
Jafari Masoud R.
Markwardt Kerry L.
Alcon Inc.
Flanigan Mark E.
Fubara Blessing M
LandOfFree
Combinations of viscoelastics for use during surgery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of viscoelastics for use during surgery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of viscoelastics for use during surgery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195072